Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 158
Aptamer sequence: ACACGCGAGAUAGAGCGAGGCCUCCAAAAAUGGCCACGCCAGGAAGCAAGU
Target unique ID: P03372
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_154 aptER-2 Protein ESR1_HUMAN 21 nM 12 mM HEPES/pH 7.6, 150 mM NaCl, and 10 mM MgCl2 24588102
Structure information of aptamer
Aptamer Sequence: ACACGCGAGAUAGAGCGAGGCCUCCAAAAAUGGCCACGCCAGGAAGCAAGU
The optimal secondary structure in dot-bracket notation: ....((........(((.((((.........)))).)))......))....
The centroid secondary structure in dot-bracket notation: ....((........(((.((((.........)))).)))......))....
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_154 Description aptER-2
Aptamer chemistry RNA Length 51 nt
GC content 56.9% Molecular weight 16,778.97 Da
Molarity of 1 μg/μl solution 59.60 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Targeted binding
Sequence ACACGCGAGAUAGAGCGAGGCCUCCAAAAAUGGCCACGCCAGGAAGCAAGU
Applications Effectively inhibited ER-mediated transcriptional activation in a breast cancer cell line
Target information
Type Detail Type Detail
Uniprot ID P03372 Protein name Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1)
Gene name(s) ESR1 ESR NR3A1 Organism Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1)
Status reviewed in uniprot database Length 595
Mass 66,216 Activity regulation N/A
Involvement in disease Estrogen resistance (ESTRR) Catalytic activity N/A
PDB ID(s)
1A52;1ERE;1ERR;1G50;1GWQ;1GWR;1HCP;1HCQ;1L2I;1PCG;1QKT;1QKU;1R5K;1SJ0;1UOM;1X7E;1X7R;1XP1;1XP6;1XP9;1XPC;1XQC;1YIM;1YIN;1ZKY;2AYR;2B1V;2B1Z;2B23;2BJ4;2FAI;2G44;2G5O;2I0J;2IOG;2IOK;2JF9;2JFA;2LLO;2LLQ;2OCF;2OUZ;2P15;2POG;2Q6J;2Q70;2QA6;2QA8;2QAB;2QE4;2QGT;2QGW;2QH6;2QR9;2QSE;2QXM;2QXS;2QZO;2R6W;2R6Y;2YAT;2YJA;3CBM;3CBO;3CBP;3DT3;3ERD;3ERT;3HLV;3HM1;3L03;3OS8;3OS9;3OSA;3Q95;3UU7;3UUA;3UUC;3UUD;4AA6;4DMA;4IU7;4IUI;4IV2;4IV4;4IVW;4IVY;4IW6;4IW8;4IWC;4IWF;4JC3;4JDD;4MG5;4MG6;4MG7;4MG8;4MG9;4MGA;4MGB;4MGC;4MGD;4O6F;4PP6;4PPP;4PPS;4PXM;4Q13;4Q50;4TUZ;4TV1;4XI3;4ZN7;4ZN9;4ZNH;4ZNS;4ZNT;4ZNU;4ZNV;4ZNW;5AAU;5AAV;5ACC;5AK2;5DI7;5DID;5DIE;5DIG;5DK9;5DKB;5DKE;5DKG;5DKS;5DL4;5DLR;5DMC;5DMF;5DP0;5DRJ;5DRM;5DTV;5DU5;5DUE;5DUG;5DUH;5DVS;5DVV;5DWE;5DWG;5DWI;5DWJ;5DX3;5DXB;5DXE;5DXG;5DXK;5DXM;5DXP;5DXQ;5DXR;5DY8;5DYB;5DYD;5DZ0;5DZ1;5DZ3;5DZH;5DZI;5E0W;5E0X;5E14;5E15;5E19;5E1C;5EGV;5EHJ;5EI1;5EIT;5FQP;5FQR;5FQS;5FQT;5FQV;5GS4;5GTR;5HYR;5JMM;5KCC;5KCD;5KCE;5KCF;5KCT;5KCU;5KCW;5KD9;5KR9;5KRA;5KRC;5KRF;5KRH;5KRI;5KRJ;5KRK;5KRL;5KRM;5KRO;5N10;5T0X;5T1Z;5T92;5T97;5TLD;5TLF;5TLG;5TLL;5TLM;5TLO;5TLP;5TLT;5TLU;5TLV;5TLX;5TLY;5TM1;5TM2;5TM3;5TM4;5TM5;5TM6;5TM7;5TM8;5TM9;5TML;5TMM;5TMO;5TMQ;5TMR;5TMS;5TMT;5TMU;5TMV;5TMW;5TMZ;5TN1;5TN3;5TN4;5TN5;5TN6;5TN7;5TN8;5TN9;5TNB;5U2B;5U2D;5UFW;5UFX;5W9C;5W9D;5WGD;5WGQ;6B0F;6C42;6CBZ;6CHW;6CHZ;6CZN;6D0F;6DF6;6DFN;6HHP;6HKB;6HKF;6HMU;6IAR;6OWC;6PET;6PFM;6PIT;6PSJ;6SBO;6SQ0;6SUO;6TJM;6TL3;6V87;6V8T;6VGH;6VIG;6VJD;6VMU;6VPF;6VPK;6VVP;6WOK;6ZOQ;6ZOR;6ZOS;7B9M;7B9R;7B9T;7BA3;7BA5;7BA6;7BA7;7BA8;7BA9;7BAA;7BAB;7JHD;7KBS;7KCA;7KCD;7MSA;7NDO;7NEL;7NFB;7NFW;7NIZ;7RRX;7RRY;7RRZ;7RS0;7RS1;7RS2;7RS3;7RS4;7RS7;7RS8;7RS9;7TE7;7UJ7;
Function Nuclear hormone receptor.
Activity data
Interaction ID 158
Target type Protein
Target unique ID P03372
Activity 21 nM
Binding Conditions/Buffer

12 mM HEPES/pH 7.6, 150 mM NaCl, and 10 mM MgCl2

Assay

Binding curves of the aptamers for ERa determined using filter-binding assays. The apparent Kd determined from binding curves is shown next to the title of each curve. Each experiment was repeated at least three times and the standard deviation was shown as error bars

PubMed ID 24588102
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_1121 RNA GACAGCGUGCCUAGAAGUCCAAGCUUAAAUAACCACGCUCGACAAGC 56.86%
Apta_155 RNA GACCCAGGGCCGGGACGCAAAGCAGCCAAAACAGACGGCCCCAGUCAGGGAGUU 53.70%
Apta_257 DNA GGCAGAAGAAATATCGAAACCCAGAATGGTCGGCCAGGCG 52.94%
Apta_875 DNA GCCGCGACCATACAACGCAAACAACACGCCTGTACGCTTG 52.94%
Apta_56 DNA GCAGCTAAGCAGGCGGCTCACAAAACCATTCGCATGCGGC 50.98%
Apta_386 DNA GGAAAAGATGGTATGGGCCCTAGAAAGTCCACCCGGCGCC 50.98%
Apta_643 DNA ACCGATCCATCGAGTTTCTGAGAAAGGCCCGGAGAAACCGCGAGA 50.98%
Apta_1013 DNA ATCACGTATGGGGGGCCGGCATGAGGGCCGCGCGTGACA 50.98%
Apta_447 RNA ACGCUCAACGAGCCAGGAACAUCGACGUCAGCAAACGCGAGCGCAACCAGUAACACC 50.88%
Apta_301 RNA AUACCAGCUUAUUCAAUUGCCUGAAAAGUUGAACUCCAAAUACGCGCUGAGAUAGUAAGUGCAAUCU 50.75%
Apta_383 RNA GGCGUGACCUGAUGAGUCACGCUAAGGAGGAUUUCCGAAAGCGGCUACGGUCCGCCAGUGUUACGAAACGUUCCC 50.67%
Apta_38 RNA GGUAGAUACGAUGGAUACCCCCUGUGGCCCGUCAACACAGGGGAAGUGGCAUGACGCGCAGCCA 50.00%
Apta_575 RNA AGAGCUUGACGGUCCCGAGAGUCGAGCCCAAGCUGACACUGGACCUUUGCGGACCACGUGUUGAUCGUCG 50.00%
Apta_1048 DNA ATACGGGAGCCAACACCACCTGCGGAAAATCAACAACGACACACGCCACGATTCAGAGCAGGTGTGACGGAT 50.00%
Apta_910 DNA TCACGTGCATGATAGACGGCGAAGCCGTCGAGTTGCTGTGTGCCGATGCACGTGA 49.09%
Apta_153 RNA CCACAGUUCAGAGGCACCGCGAACAAAACGCAAGACAGAGUGCCGACAAGAAC 49.06%
Apta_86 RNA GAAACGACUCGACAACCUCGAGCGACGUGAAUCAU 49.02%
Apta_87 RNA UACCGACUAGCAAAACCUGCUGGCGACGUUUAGAU 49.02%
Apta_513 DNA TAGGGAAAACCAACCGCCCAGAACTGCAGCATAAC 49.02%
Apta_588 RNA CCGGUGCGCAUAACCACCUCAGUGCGAGCAAGGAA 49.02%